# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-21-036239
Filing Date
2021-02-10
Accepted
2021-02-10 16:05:02
Documents
153
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | d102112d10k.htm iXBRL | 10-K | 4842076
2 | EX-10.7 | d102112dex107.htm | EX-10.7 | 144013
3 | EX-10.8 | d102112dex108.htm | EX-10.8 | 84016
4 | EX-10.9 | d102112dex109.htm | EX-10.9 | 40253
5 | EX-21 | d102112dex21.htm | EX-21 | 6996
6 | EX-23 | d102112dex23.htm | EX-23 | 2567
7 | EX-31.1 | d102112dex311.htm | EX-31.1 | 10643
8 | EX-31.2 | d102112dex312.htm | EX-31.2 | 10515
9 | EX-32 | d102112dex32.htm | EX-32 | 4950
15 | GRAPHIC | g102112g01r43.jpg | GRAPHIC | 56510
16 | GRAPHIC | g102112g0203043727908.jpg | GRAPHIC | 1944
17 | GRAPHIC | g102112page186a.jpg | GRAPHIC | 16954
| Complete submission text file | 0001193125-21-036239.txt |  | 20978088

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20201231.xsd | EX-101.SCH | 137109
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20201231_cal.xml | EX-101.CAL | 75518
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20201231_def.xml | EX-101.DEF | 858173
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20201231_lab.xml | EX-101.LAB | 927179
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20201231_pre.xml | EX-101.PRE | 931737
18 | EXTRACTED XBRL INSTANCE DOCUMENT | d102112d10k_htm.xml | XML | 4452258

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16174 | Film No.: 21613756
SIC: 2834 Pharmaceutical Preparations